Nitrofurantoin and Macrocrystalline
Nitrofurantoin and Macrocrystalline comes in 8 pill versions in our database, in 3 strengths, from 6 manufacturers. Check the imprint to tell them apart.
Nitrofurantoin and Macrocrystalline pill images
25 mg / 75 mg 3 pills
- Macrobid 52427285 Nitrofurantoin/Macrocrystalline 25 mg / 75 mg Black & yellow, capsule, 20 mm Used for urinary tract infections (UTIs)
- Macrobid 52427285 Nitrofurantoin/Macrocrystalline 25 mg / 75 mg Black & yellow, capsule, 20 mm Used for urinary tract infections (UTIs)
- Macrobid 52427285 Nitrofurantoin/ Macrocrystalline 25 mg / 75 mg Black & yellow, capsule, 20 mm Used for urinary tract infections (UTIs)
75 mg / 25 mg 1 pill
Other 4 pills
- Macrobid Norwich Eaton Nitrofurantoin and Nitrofurantoin, Macrocrystalline Black & yellow, capsule, 20 mm Used for urinary tract infections (UTIs)
- Macrodantin 25 mg 0149-0007 Nitrofurantoin, Macrocrystalline White, oval, 14 mm Used for urinary tract infections (UTIs)
- Macrodantin 50 mg 0149-0008 Nitrofurantoin, Macrocrystalline White & yellow, oval, 16 mm Used for urinary tract infections (UTIs)
- Macrodantin 100 mg 0149-0009 Nitrofurantoin, Macrocrystalline Yellow, oval, 18 mm Used for urinary tract infections (UTIs)
What is Nitrofurantoin and Macrocrystalline used for?
Nitrofurantoin and Macrocrystalline is used for urinary tract infections (UTIs).
- Medicine type
- Antibiotic
Official uses from the US prescribing label
Macrodantin is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.
Nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Macrodantin and other antibacterial drugs, Macrodantin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections. Consequently, many patients who are treated with Macrodantin are predisposed to persistence or reappearance of bacteriuria. Urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy. If persistence or reappearance of bacteriuria occurs after treatment with Macrodantin, other therapeutic agents with broader tissue distribution should be selected. In considering the use of Macrodantin, lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized.
From the FDA-approved label on DailyMed (published Apr 21, 2009).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.